From Medscape Neurology

Coverage from the

American Academy of Neurology (AAN) 2019 Annual Meeting

May 04 - 10, 2019; Philadelphia, Pennsylvania

May 04 - 10, 2019 Philadelphia, Pennsylvania

AAN 2019 New AAN Guideline on Tourette Syndrome, Tic Disorders The first guideline for US neurologists advocates Comprehensive Behavioral Intervention for Tics (CBIT) as first-line therapy for Tourette syndrome and other chronic tic disorders.
Medscape Medical News, May 6, 2019
AAN 2019 Experimental Agent Shows Promise in Slowing Genetic Form of ALS Researchers successfully target elevated levels of a harmful protein, offering hope to people with a genetic form of amyotrophic lateral sclerosis.
Medscape Medical News, May 2, 2019
AAN 2019 Blood Pressure Drug Disappoints in Slowing Parkinson's Despite previous research suggesting the calcium channel blocker isradipine may slow progression of Parkinson's disease, results of a new phase 3 placebo-controlled study suggest this is not the case.
Medscape Medical News, May 2, 2019

Conference News

AAN 2019 Only 1 in 5 With High-Risk AF Leave ED on Anticoagulant
Medscape Medical News, May 17, 2019
AAN 2019 Zilucoplan May Decrease Symptoms of Myasthenia Gravis
Medscape Medical News, May 15, 2019
AAN 2019 Latest Data on Evobrutinib, New MS Therapy Targeting B Cells
Medscape Medical News, May 13, 2019
AAN 2019 Experimental Agent Offers First Hope for Rare Genetic Disorder
Medscape Medical News, May 13, 2019
AAN 2019 Botulinum Toxin Effective for BEB in Toxin-Naive Patients
Medscape Medical News, May 10, 2019
AAN 2019 LEGATO-HD: Laquinimod Misses Primary Aim in Huntington's
Medscape Medical News, May 9, 2019
AAN 2019 Novel Treatment for Huntington's Shows Early Promise
Medscape Medical News, May 8, 2019
AAN 2019 Immunotherapy Using Donor Cells Safe in PML
Medscape Medical News, May 7, 2019
AAN 2019 Novel Drug Eases Charcot-Marie-Tooth Disability in Phase 3 Trial
Medscape Medical News, May 7, 2019
AAN 2019 Brain Healthy Behaviors Aid Patients With MCI, Mild Dementia
Medscape Medical News, May 7, 2019
AAN 2019 Once-Daily Opicapone Adds 'On Time' in PD Phase 3 Studies
Medscape Medical News, May 6, 2019
AAN 2019 New AAN Guideline on Tourette Syndrome, Tic Disorders
Medscape Medical News, May 6, 2019
AAN 2019 Female Athletes at Greater Risk for Post-Concussion Injuries
Medscape Medical News, May 6, 2019

AAN 2019 Medical Cannabis Safe, Effective in the Elderly
Medscape Medical News, May 6, 2019
AAN 2019 DUOGLOBE Interim Results: Intestinal Gel Cuts PD 'Off' Time
Medscape Medical News, May 5, 2019
AAN 2019 PREVENT: Eculizumab May Lower Relapse Risk in NMOSD
Medscape Medical News, May 4, 2019
AAN 2019 Experimental Agent Shows Promise in Slowing Genetic Form of ALS
Medscape Medical News, May 2, 2019
AAN 2019 Blood Pressure Drug Disappoints in Slowing Parkinson's
Medscape Medical News, May 2, 2019
AAN 2019 Seizures Cut in Half After CBD Use in Dravet Syndrome
Medscape Medical News, May 2, 2019
AAN 2019 What's Hot at AAN 2019?
Medscape Medical News, May 1, 2019
AAN 2019 MS May Not Worsen After Childbirth After All
Medscape Medical News, March 27, 2019
AAN 2019 NOMAS: Depression Tied to Increased Stroke Risk
Medscape Medical News, March 20, 2019
AAN 2019 FAST-MAG: Higher BMI Linked to Better Post-Stroke Survival
Medscape Medical News, March 14, 2019
AAN 2019 Sugary Drinks Linked to Higher Disability in MS
Medscape Medical News, March 7, 2019
AAN 2019 Sleep Apnea Tied to Higher Levels of Alzheimer Protein
Medscape Medical News, March 5, 2019
AAN 2019 Playing Professional Soccer Linked to Increased ALS Risk
Medscape Medical News, March 4, 2019

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Which Patients Qualify for Thrombectomy in Large Vessel Stroke?
Mark J. Alberts, MD
Making Sense of Neurofilament Light in MS
Stephen Krieger, MD
Why Students Become Neurologists
Stephen Krieger, MD
The Rise of Intranasal Treatments in Epilepsy
Andrew N. Wilner, MD
Risk for Stroke in Pregnancy and the Postpartum Period
Mark J. Alberts, MD
What Lies Ahead for Dementia Therapy
Andrew N. Wilner, MD
Monoclonals for Migraine: 'Probably the Best Option We've Ever Had'
Andrew N. Wilner, MD
When a Neurology Consult Is Unnecessary
Stephen Krieger, MD
How Video Games Change the Brain
Bret Stetka, MD
Improving Stroke Outcomes Through Mobile Care, At Least in NYC
Bret Stetka, MD

Popular News from AAN 2018

DASH Diet Linked to Lower Risk for Depression A diet developed to control hypertension is now proving helpful for reducing depression as well, researchers report.
Medscape Medical News, Feb 28, 2018
Cerliponase Alfa May Slow Symptoms of CLN2 Disease in Children Enzyme-replacement therapy with intraventricular cerliponase alfa may delay motor and language declines in ceroid lipofuscinosis type 2 (CLN2) disease, a fatal neurodegenerative disorder.
Medscape Medical News, Apr 25, 2018
New AAN Guidelines Advocate Early MS Treatment New guidelines update guidance on starting, switching, and stopping disease-modifying therapies in multiple sclerosis and recommend an earlier, rather than later, start to treatment.
Medscape Medical News, Apr 23, 2018

Previous Coverage

Related Resource